See what the IHS Markit Score report has to say about Maiden Holdings Ltd.
Posted on Saturday September 15, 2018

The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Financials sector is rising.

Maiden Holdings' (MHLD) Divestment Nod to Boost Portfolio
Posted on Monday September 03, 2018

Maiden Holdings (MHLD) agrees to sell its U.S. diversified business to Enstar Holdings and expects this deal to enhance its capabilities and operational efficiencies.

Maiden Holdings Announces Sale of U.S. Diversified Business to Enstar Holdings (US) LLC
Posted on Friday August 31, 2018

Maiden Holdings, Ltd. (MHLD) (“Maiden” or the “Company”) announced today that it has entered into an agreement to sell Maiden Reinsurance North America, Inc. (“MRNA”), the Company’s U.S. domestic insurance company, to Enstar Holdings (US) LLC (“Enstar”) for net proceeds of $307.5 million and subject to certain closing adjustments. The transaction, which is expected to close in the fourth quarter of 2018, does not include any of the Bermuda underwriting elements of Maiden’s portfolio including its AmTrust Business or its International Insurance Services and Capital Solutions businesses in Europe, which forms the significant majority of Maiden’s existing business and will remain as part of its on-going business.

Maiden Holdings Announces Sale of U.S. Treaty Reinsurance Renewal Rights to TransRe and Update on Strategic Review
Posted on Wednesday August 29, 2018

Maiden Holdings, Ltd. (MHLD) (“Maiden” or the “Company”) announced today that it has sold the renewal rights in respect of its U.S. treaty reinsurance underwriting business to Transatlantic Reinsurance Company (“TransRe”). The transaction, which has now closed, does not include any of the Bermuda underwriting elements of Maiden’s portfolio including its AmTrust Business or its International Insurance Services and Capital Solutions businesses in Europe, which forms the significant majority of Maiden’s existing business and will remain as part of its on-going business. The Company also reported that in connection with its previously announced strategic review, it is in advanced discussions regarding the sale of its wholly-owned subsidiary, Maiden Reinsurance North America, Inc. (“MRNA”) to a third party.  The transaction would cover approximately $1.1 billion of loss and LAE reserves as of June 30, 2018.